Buy me a coffee
Home › FDA recalls › Methohexital Sodium for Injection
CLASS II · ModerateFDA

ONESOURCE SPECIALTY PHARMA LIMITED recalls Methohexital Sodium for Injection

📅 Jun 7, 2026 · 📍 Nationwide
Recalling company
ONESOURCE SPECIALTY PHARMA LIMITED
Product
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Reason
Failed Impurities/Degradation Specifications
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Jun 7, 2026
Reported
Jul 15, 2026
Distribution
Nationwide within the United States
Status
Ongoing
Quantity
4284 vials
Lot / codes
Lot #: 7000612A, Exp. Date 1/2028
Company location
Bengaluru, N/A
Recall type
Voluntary: Firm initiated
Recall number
D-0662-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0662-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.